Effects of Add-on Fluvastatin Therapy in Patients with Chronic Proteinuric Nephropathy on Dual Renin-Angiotensin System Blockade: The ESPLANADE Trial-Reference-Cited by-同舟云学术

Effects of Add-on Fluvastatin Therapy in Patients with Chronic Proteinuric Nephropathy on Dual Renin-Angiotensin System Blockade: The ESPLANADE Trial

Published:2010-07-29 Issue:11 Volume:5 Page:1928-1938
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Ruggenenti Piero,Perna Annalisa,Tonelli Marcello,Loriga Giacomina,Motterlini Nicola,Rubis Nadia,Ledda Franca,Rota Stefano,Satta Andrea,Granata Antonio,Battaglia Giovanni,Cambareri Francesco,David Salvatore,Gaspari Flavio,Stucchi Nadia,Carminati Sergio,Ene-Iordache Bogdan,Cravedi Paolo,Remuzzi Giuseppe,

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference37 articles.

1. Chronic Kidney Disease and Mortality Risk: A Systematic Review

2. Retarding progression of chronic renal disease: The neglected issue of residual proteinuria

3. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial

4. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences

5. Albumin Signals the Coming of Age of Proteinuric Nephropathy

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29

2. Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials;Advances in Therapy;2021-12-08

3. Efficacy of statins on renal function in patients with chronic kidney disease: a systematic review and meta-analysis;Renal Failure;2021-01-01

4. Approach to the Patient with Chronic Glomerular Disease;Chronic Renal Disease;2020

5. Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directions;Reviews in Cardiovascular Medicine;2019-09-30